Consumer Advisory Committee (CAC)
The Consumer Advisory Committee (CAC) provides PHARMAC with input from a patient or health consumer perspective. It was established in 2002 following the requirements of the New Zealand Public Health and Disability Act 2000 and provides advice to PHARMAC on a broad range of PHARMAC's activities, including around medicines funding issues. It is not, however, involved in the assessment of pharmaceutical funding applications.
The Committee meets at least twice a year, and is guided by its Terms of Reference (26 pages, 586 KB). Minutes of meetings are available here.
For more information about the Consumer Advisory Committee, read Listening to Consumers - Role of the Consumer Advisory Committee (2 pages, 90 KB)
New Committee Members
PHARMAC has appointed five new CAC members. You can read about them here and read the media release. (2 pages, 105 KB)
Page updated on 19 Aug 2010
Linked documents
Consumer Advisory Committee Terms of Reference (26 pages, 586 KB)
1 CONTENTS 1 2 3 Establishment…4 1.1 2.1 3.1 3.2 3.3 4 5 6 7 8 4.1 The CAC …..4 Purpose of the CAC …4 Relationship with PHARMAC…..5 Relationship with PHARMAC staff…5 Indemnity for Members…..6 Appointment of the CAC Members…
Listening to Consumers - role of the Consumer Advisory Committee (2 pages, 90 KB)
PHARMAC Information sheet Listening to consumers - Role of the Consumer Advisory Committee The Consumer Advisory Committee (CAC) helps PHARMAC better understand consumer and patient perspectives. CAC Consumer Advisory Committee Considering Consumer perspectives Our work directly affects the lives of…
New CAC members announced (2 pages, 105 KB)
19 August 2010 Media release Five new members for PHARMAC consumer committee The PHARMAC Board has appointed five new members to the Government drug funder’s Consumer Advisory Committee. The refreshed membership follows a review of the Committee’s Terms of Reference,…
